The Cost of Imperfection: Recurrence‐Adjusted Costs of Sphincter‐Preserving Procedures for Complex Anal Fistula in Australia
- 1Department of Colorectal Surgery Bankstown‐Lidcombe Hospital, South Western Sydney Local Health District Sydney New South Wales Australia
- 2School of Clinical Medicine University of New South Wales Sydney New South Wales Australia
- 3School of Medicine University of Sydney Sydney New South Wales Australia
Abstract
Background: Complex cryptoglandular anal fistula is frequently complicated by treatment failure, repeat intervention and ongoing healthcare use. Economic evaluations are limited, rarely incorporate failure‐related re‐intervention, and seldom distinguish between public and private settings. This study compared 12‐month pathway costs for ligation of the inter‐sphincteric fistula tract (LIFT), endorectal advancement flap (ERAF), video‐assisted anal fistula treatment (VAAFT) and non‐definitive seton management in Australia.
Methods: A micro‐costing analysis was performed using 2023–24 Australian public and private hospital data. Costs were calculated from the hospital perspective and incorporated procedures required after treatment failure over 12 months, reflecting pathway costs rather than index procedure costs. Failure rates and re‐intervention pathways were derived from a prospectively maintained cohort treated within a single colorectal surgical network (LIFT n = 88; ERAF n = 16; VAAFT n = 22). Non‐definitive seton management was modelled as one, two or four planned operative episodes per year.
Results: Crude observed 12‐month treatment failure was similar across definitive procedures (LIFT 36%, ERAF 38%, VAAFT 36%). Pathway costs incorporating treatment failure were AUD 1846/8858 for LIFT, AUD 2161/9164 for ERAF, and AUD 1937–2968/8870–10 499 for VAAFT in public/private hospitals, depending on case volume. Seton management cost AUD 871–3484/5050–20 200 per year, depending on operative frequency.
Conclusion: Incorporating treatment failure narrowed cost differences between definitive sphincter‐preserving techniques. Non‐definitive seton costs were frequency‐dependent. Local case volume, admission pathway, and failure burden should inform service planning and VAAFT adoption.
Related
- Anterolateral Thigh Island Flap Reconstruction After Margin-Positive, Sphincter-Preserving Excision of Scrotal Extramammary Paget’s Disease: A Case Report
- Secondary Perianal Extramammary Paget's Disease Originating from a High-Grade Tubular Villous Adenoma Treated with Sphincter-Preserving Wide Local Excision and VY Advancement Flap: A Case Report.
- Does omission of a loose seton before sphincter-preserving surgery achieve non-inferior fistula closure compared with routine loose seton placement in adults with single-tract cryptoglandular anal fistula in the Netherlands? Study protocol for the SETON multicentre randomised controlled non-inferiority trial and cost-utility analysis
- Improving Immediate Postpartum Detection of Obstetric Anal Sphincter Injury: Added Diagnostic Value of Impedance Spectroscopy Following Clinical Assessment
- Case Report of a Complex Colovesical Fistula Associated With an Infected Artificial Urinary Sphincter: Radiological and Clinical Manifestations and Treatment Discussion
BibTeX
@article{irwin2026cost,
title = {{The Cost of Imperfection: Recurrence‐Adjusted Costs of Sphincter‐Preserving Procedures for Complex Anal Fistula in Australia}},
author = {Matthew P. Irwin and Matthew J. Morgan and Catherine E. Turner and Kevin C. Ooi and Yang Yu},
journal = {Anz Journal of Surgery},
year = {2026},
month = jul,
doi = {10.1111/ans.70872},
url = {https://doi.org/10.1111/ans.70872},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - The Cost of Imperfection: Recurrence‐Adjusted Costs of Sphincter‐Preserving Procedures for Complex Anal Fistula in Australia
AU - Matthew P. Irwin
AU - Matthew J. Morgan
AU - Catherine E. Turner
AU - Kevin C. Ooi
AU - Yang Yu
PY - 2026
DA - 2026/07/19
JO - Anz Journal of Surgery
DO - 10.1111/ans.70872
UR - https://doi.org/10.1111/ans.70872
AB - Background: Complex cryptoglandular anal fistula is frequently complicated by treatment failure, repeat intervention and ongoing healthcare use. Economic evaluations are limited, rarely incorporate failure‐related re‐intervention, and seldom distinguish between public and private settings. This study compared 12‐month pathway costs for ligation of the inter‐sphincteric fistula tract (LIFT), endorectal advancement flap (ERAF), video‐assisted anal fistula treatment (VAAFT) and non‐definitive seton management in Australia. Methods: A micro‐costing analysis was performed using 2023–24 Australian public and private hospital data. Costs were calculated from the hospital perspective and incorporated procedures required after treatment failure over 12 months, reflecting pathway costs rather than index procedure costs. Failure rates and re‐intervention pathways were derived from a prospectively maintained cohort treated within a single colorectal surgical network (LIFT n = 88; ERAF n = 16; VAAFT n = 22). Non‐definitive seton management was modelled as one, two or four planned operative episodes per year. Results: Crude observed 12‐month treatment failure was similar across definitive procedures (LIFT 36%, ERAF 38%, VAAFT 36%). Pathway costs incorporating treatment failure were AUD 1846/8858 for LIFT, AUD 2161/9164 for ERAF, and AUD 1937–2968/8870–10 499 for VAAFT in public/private hospitals, depending on case volume. Seton management cost AUD 871–3484/5050–20 200 per year, depending on operative frequency. Conclusion: Incorporating treatment failure narrowed cost differences between definitive sphincter‐preserving techniques. Non‐definitive seton costs were frequency‐dependent. Local case volume, admission pathway, and failure burden should inform service planning and VAAFT adoption.
SN - 1445-1433
SN - 1445-2197
ER -